The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products

被引:21
作者
Barrera, Giuseppina [1 ]
Toaldo, Cristina [1 ]
Pizzimenti, Stefania [1 ]
Cerbone, Angelo [2 ]
Pettazzoni, Piergiorgio [1 ]
Dianzani, Mario Umberto [1 ]
Ferretti, Carlo [3 ]
机构
[1] Dipartimento Med & Oncol Sperimentale, Sez Patol Gen, I-10125 Turin, Italy
[2] Ist Ric Biomed A Marxer RBM Merck Serono, I-10010 Turin, Italy
[3] Dipartimento Anat Farmacol & Med Legale, Sez Farmacol, I-10125 Turin, Italy
关键词
D O I
10.1155/2008/524671
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome proliferators-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. The three PPAR isoforms (alpha, gamma and beta/delta) have been found to play a pleiotropic role in cell fat metabolism. Furthermore, in recent years, evidence has been found regarding the antiproliferative, proapoptotic, and differentiation-promoting activities displayed by PPAR gamma ligands, particularly by PPAR. ligands. PPAR ligands affect the expression of different growth-related genes through both PPAR-dependent and PPAR-independent mechanisms. Moreover, an interaction between PPAR ligands and other molecules which strengthen the effects of PPAR ligands has been described. Here we review the action of PPAR on the control of gene expression with particular regard to the effect of PPAR ligands on the expression of genes involved in the regulation of cell-cycle, differentiation, and apoptosis. Moreover, the interaction between PPAR ligands and 4-hydroxynonenal (HNE), the major product of the lipid peroxidation, has been reviewed. Copyright (C) 2008 Giuseppina Barrera et al.
引用
收藏
页数:15
相关论文
共 175 条
  • [51] Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor γ
    Gauthier, A
    Vassiliou, G
    Benoist, F
    McPherson, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) : 11945 - 11953
  • [52] Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ
    Ghisletti, Serena
    Huang, Wendy
    Ogawa, Sumito
    Pascual, Gabriel
    Lin, Mu-En
    Willson, Timothy M.
    Rosenfeld, Michael G.
    Glass, Christopher K.
    [J]. MOLECULAR CELL, 2007, 25 (01) : 57 - 70
  • [54] RB and cell cycle progression
    Giacinti, C.
    Giordano, A.
    [J]. ONCOGENE, 2006, 25 (38) : 5220 - 5227
  • [55] Combinatorial roles of nuclear receptors in inflammation and immunity
    Glass, CK
    Ogawa, S
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (01) : 44 - 55
  • [56] Gouni-Berthold I, 2001, N-S ARCH PHARMACOL, V363, P215
  • [57] Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Δ12,14-prostaglandin J2 in colon carcinoma cells:: Evidence for a redox-sensitive peroxisome proliferator-activated receptor-γ-independent mechanism
    Grau, R
    Iñiguez, MA
    Fresno, M
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5162 - 5171
  • [58] Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells
    Gupta, RA
    Brockman, JA
    Sarraf, P
    Willson, TM
    DuBois, RN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 29681 - 29687
  • [59] Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth
    Gupta, RA
    Wang, DZ
    Katkuri, S
    Wang, HB
    Dey, SK
    DuBois, RN
    [J]. NATURE MEDICINE, 2004, 10 (03) : 245 - 247
  • [60] Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα
    Hanley, K
    Jiang, Y
    He, SS
    Friedman, M
    Elias, PM
    Bikle, DD
    Williams, ML
    Feingold, KR
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 368 - 375